JP2017518982A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017518982A5 JP2017518982A5 JP2016567865A JP2016567865A JP2017518982A5 JP 2017518982 A5 JP2017518982 A5 JP 2017518982A5 JP 2016567865 A JP2016567865 A JP 2016567865A JP 2016567865 A JP2016567865 A JP 2016567865A JP 2017518982 A5 JP2017518982 A5 JP 2017518982A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- epiamb
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461994450P | 2014-05-16 | 2014-05-16 | |
| US61/994,450 | 2014-05-16 | ||
| US201462045907P | 2014-09-04 | 2014-09-04 | |
| US62/045,907 | 2014-09-04 | ||
| PCT/US2015/030965 WO2015175875A1 (en) | 2014-05-16 | 2015-05-15 | Amphotericin b derivative with reduced toxicity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017518982A JP2017518982A (ja) | 2017-07-13 |
| JP2017518982A5 true JP2017518982A5 (enExample) | 2018-06-28 |
| JP6543272B2 JP6543272B2 (ja) | 2019-07-10 |
Family
ID=54480735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567865A Active JP6543272B2 (ja) | 2014-05-16 | 2015-05-15 | 低減された毒性を有するアンホテリシンｂ誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9738677B2 (enExample) |
| EP (1) | EP3142672B1 (enExample) |
| JP (1) | JP6543272B2 (enExample) |
| CA (1) | CA2981288C (enExample) |
| DK (1) | DK3142672T3 (enExample) |
| ES (1) | ES2749927T3 (enExample) |
| WO (1) | WO2015175875A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016061437A1 (en) | 2014-10-17 | 2016-04-21 | The Board Of Trustees Of The University Of Illinois | Scalable synthesis of reduced toxicity derivative of amphotericin b |
| EP3283171B1 (en) | 2015-04-15 | 2021-05-26 | Sfunga Therapeutics, Inc. | Derivatives of amphotericin b |
| CN113056274A (zh) | 2018-09-07 | 2021-06-29 | 伊利诺伊大学评议会 | 具有降低的毒性的杂化两性霉素b衍生物 |
| WO2021026450A1 (en) * | 2019-08-08 | 2021-02-11 | The Board Of Trustees Of The University Of Illinois | Hybrid amphotericin b derivatives with reduced toxicity |
| WO2021030183A1 (en) * | 2019-08-09 | 2021-02-18 | The Board Of Trustees Of The University Of Illinois | Combination treatment of systemic fungal infections |
| MX2023001649A (es) * | 2020-08-10 | 2023-04-24 | Univ Illinois | Derivados de amida hibrida de anfotericina b. |
| EP4551584A2 (en) * | 2022-07-08 | 2025-05-14 | The Board Of Trustees Of The University Of Illinois | Transfer of c2'-epimerized sugars to the amphotericin b aglycone |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006528704A (ja) * | 2003-05-27 | 2006-12-21 | セラヴァンス インコーポレーテッド | グリコペプチド抗細菌剤と組み合わせたポリエンマクロライド抗真菌剤の使用 |
| CN101442989B (zh) * | 2004-06-21 | 2013-04-03 | 诺瓦帝斯公司 | 包括两性霉素b的组合物 |
| US8513204B2 (en) * | 2004-06-21 | 2013-08-20 | Novartis Ag | Compositions comprising amphotericin B, mehods and systems |
| WO2014059436A1 (en) * | 2012-10-12 | 2014-04-17 | The Board Of Trustees Of The University Of Illinois | Electronic tuning of site selectivity |
| WO2016061437A1 (en) * | 2014-10-17 | 2016-04-21 | The Board Of Trustees Of The University Of Illinois | Scalable synthesis of reduced toxicity derivative of amphotericin b |
-
2015
- 2015-05-15 WO PCT/US2015/030965 patent/WO2015175875A1/en not_active Ceased
- 2015-05-15 CA CA2981288A patent/CA2981288C/en active Active
- 2015-05-15 JP JP2016567865A patent/JP6543272B2/ja active Active
- 2015-05-15 DK DK15793421.7T patent/DK3142672T3/da active
- 2015-05-15 US US15/310,815 patent/US9738677B2/en active Active
- 2015-05-15 EP EP15793421.7A patent/EP3142672B1/en active Active
- 2015-05-15 ES ES15793421T patent/ES2749927T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017518982A5 (enExample) | ||
| JP2014507446A5 (enExample) | ||
| JP2017186358A5 (enExample) | ||
| JP2017509667A5 (enExample) | ||
| JP2017537066A5 (enExample) | ||
| JP2019516735A5 (enExample) | ||
| JP2017105793A5 (enExample) | ||
| JP2013014622A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2021191784A5 (enExample) | ||
| WO2018234568A3 (en) | HYDROXYNORKETAMINE FOR USE IN TREATING DEPRESSION | |
| JP2012092123A5 (enExample) | ||
| JP2018531941A5 (enExample) | ||
| JP2013519675A5 (enExample) | ||
| EP4316591A3 (en) | Oxysterols and methods of use thereof | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| ME02910B (me) | Spojevi tetrahidropirolotiazina | |
| EP3731847A4 (en) | PULSED ADMINISTRATION OF INHALED NITROGEN OXIDE FOR THE TREATMENT OF PULMONIC HYPERTENSION | |
| UY36981A (es) | Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana | |
| JP2020097577A5 (enExample) | ||
| RU2017116740A (ru) | Комбинации для лечения рассеянного склероза | |
| JP2017505809A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| AR108712A1 (es) | (5r)-5-[3-[(3s)-4-(4-cloro-3-metoxi-5-metil-fenil)-3-metil-piperazin-1-il]-3-oxo-propil]-5-metil-imidazolidin-2,4-diona, composiciones farmacéuticas del mismo para el tratamiento de trastornos inflamatorios y osteoartritis | |
| JP2018145180A5 (enExample) |